222 results on '"Woolley, Ann E"'
Search Results
2. 18F-FDG PET/CT and Radiolabeled Leukocyte SPECT/CT Imaging for the Evaluation of Cardiovascular Infection in the Multimodality Context: ASNC Imaging Indications (ASNC I2) Series Expert Consensus Recommendations From ASNC, AATS, ACC, AHA, ASE, EANM, HRS, IDSA, SCCT, SNMMI, and STS
3. Welcoming Discourse on the Approach for Gram-Negative Bacteremia and Candidemia in Cardiovascular Implantable Electronic Device Infections
4. The International Society for Heart and Lung Transplantation/Heart Failure Society of America Guideline on Acute Mechanical Circulatory Support
5. Diagnostic TR-FRET assays for detection of antibodies in patient samples
6. The Cost-effectiveness of Transplanting Hearts From Hepatitis C-infected Donors Into Uninfected Recipients
7. Neuroinvasive Bacillus cereus Infection in Immunocompromised Hosts: Epidemiologic Investigation of 5 Patients With Acute Myeloid Leukemia
8. 1993. Donor-Derived Transmission of Candida species: 10-year Analysis from the OPTN ad hoc Disease Transmission Advisory Committee (DTAC)
9. 2707. Complications of Babesiosis in Immunocompromised and Asplenic/Hyposplenic Patients
10. 2714. Invasive Fungal Disease in Lung Transplant Recipients: Incidence, Risk Factors, and Outcomes
11. 2409. Potential candidates for partial oral treatment in patients with endocarditis at a US center
12. 1452. Neuroinvasive Bacillus Cereus Infection Amongst Immunocompromised Patients: Epidemiological Investigation of 5 Cases in Patients with Acute Myeloid Leukemia
13. Humoral signatures of protective and pathological SARS-CoV-2 infection in children
14. Early clinical and sociodemographic experience with patients hospitalized with COVID-19 at a large American healthcare system
15. BK virus–specific T-cell immune reconstitution after allogeneic hematopoietic cell transplantation
16. Utilization of hepatitis C virus–infected organ donors in cardiothoracic transplantation: An ISHLT expert consensus statement
17. 218.2: Successful abdominal organ recovery from a donor with penetrating bowel trauma
18. Dasatinib Use and Risk of Cytomegalovirus Reactivation After Allogeneic Hematopoietic-Cell Transplantation
19. Transplanting COVID-19–Positive Donor Hearts
20. OPTN required SARS‐CoV‐2 lower respiratory testing for lung donors: Striking the balance
21. Transplant of organs from donors with positive SARS‐CoV‐2 nucleic acid testing: A report from the organ procurement and transplantation network ad hoc disease transmission advisory committee
22. Nirmatrelvir Plus Ritonavir for Early COVID-19 in a Large U.S. Health System
23. Blastomycosis in New England: 5 Cases and a Review
24. 2123. The Impact of Staphylococcus aureus Peri-transplant Cultures on Six-Month Outcomes in Lung Transplantation
25. 209. Epstein-Barr Virus Surveillance in Lung Transplantation: Post-transplant Lymphoproliferative Disorder and Impact on Survival
26. A collaborative stewardship of OPOs and transplant centers to maintain equitable allocation when facilitating ex vivo organ preservation
27. Expanding the Donor Pool With Use of Hepatitis C Infected Hearts: An Unfulfilled Promise
28. Bebtelovimab for High-Risk Outpatients With Early COVID-19 in a Large US Health System
29. Prior SARS‐CoV‐2 Infection Is Associated With Coronary Vasomotor Dysfunction as Assessed by Coronary Flow Reserve From Cardiac Positron Emission Tomography
30. Thrombosis-Related Loss of Arterial Lines in the First Wave of COVID-19 and Non–COVID-19 Intensive Care Unit Patients
31. At-home Testing and Risk Factors for Acquisition of SARS-CoV-2 Infection in a Major US Metropolitan Area
32. A Current Approach to Evaluate the Risk of COVID-19 Transmission From an Organ Donor to Increase Organ Utilization
33. Nirmatrelvir plus ritonavir for early COVID-19 and hospitalization in a large US health system
34. Feasibility and lessons learned on remote trial implementation from TestBoston, a fully remote, longitudinal, large-scale COVID-19 surveillance study
35. Epidemiology and Management of ST‐Segment–Elevation Myocardial Infarction in Patients With COVID‐19: A Report From the American Heart Association COVID‐19 Cardiovascular Disease Registry
36. Cluster of Burkholderia cepacia Complex Infections Associated With Extracorporeal Membrane Oxygenation Water Heater Devices
37. At-home Testing and Risk Factors for Acquisition of SARS-CoV-2 Infection in a Major US Metropolitan Area
38. sj-docx-1-jpc-10.1177_21501319211067349 ��� Supplemental material for Serum Sodium, Patient Symptoms, and Clinical Outcomes in Hospitalized Patients with COVID-19
39. Post-Babesiosis Warm Autoimmune Hemolytic Anemia
40. Thrombosis-Related Loss of Arterial Lines in the First Wave of COVID-19 and Non–COVID-19 Intensive Care Unit Patients.
41. Relationship Between Myocardial Injury During Index Hospitalization for SARS‐CoV‐2 Infection and Longer‐Term Outcomes
42. Serum Sodium, Patient Symptoms, and Clinical Outcomes in Hospitalized Patients with COVID-19
43. A SARS‐CoV‐2 Neutralization Assay Using Single Molecule Arrays
44. 24. Longitudinal Assessment of Immune Responses to COVID-19 Vaccines in Solid Organ Transplant Recipients
45. 94. Infectious Complications of Left Ventricular Assist Devices
46. The Cost-effectiveness of Transplanting Hearts From Hepatitis C-infected Donors Into Uninfected Recipients
47. Feasibility and lessons learned on remote trial implementation from TestBoston, a fully remote, longitudinal, large-scale COVID-19 surveillance study
48. Harnessing the Potential of Multiomics Studies for Precision Medicine in Infectious Disease
49. Determining the Incidence of Asymptomatic SARS-CoV-2 Among Early Recipients of COVID-19 Vaccines (DISCOVER-COVID-19): A Prospective Cohort Study of Healthcare Workers Before, During and After Vaccination
50. Evaluation of Three Commercial and Two Non-Commercial Immunoassays for the Detection of Prior Infection to SARS-CoV-2
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.